germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Fundació</strong> <strong>Institut</strong> <strong>d'Investigació</strong><br />
<strong>en</strong> <strong>Ciències</strong> <strong>de</strong> la Salut<br />
Germans Trias i Pujol<br />
Sabariegos R, Gim<strong>en</strong>ez‐Barcons M, Tapia N,<br />
Clotet B, Martinez MA.<br />
Sequ<strong>en</strong>ce homology required by human<br />
immuno<strong>de</strong>fici<strong>en</strong>cy virus type 1 to escape from<br />
short interfering RNAs.<br />
J VIROL 2006; 80(2):571‐577.<br />
5,341<br />
Sirera G, Vi<strong>de</strong>la S, Pinol M, Canadas MP, Llatjos M, Ballesteros AL, Garcia‐Cuyas F, Castella E, Guerola R, Tural C, Rey‐Joly C,<br />
Clotet B.<br />
High preval<strong>en</strong>ce of human papillomavirus infection in the anus, p<strong>en</strong>is and mouth in HIV‐positive m<strong>en</strong>.<br />
Aids 20(8):1201‐1204.<br />
5,632<br />
Van <strong>de</strong> Vijver DA, W<strong>en</strong>sing AM, Angarano G, Asjo B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A,<br />
Der<strong>de</strong>linckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kucherer C, Leitner T, Loveday<br />
C, MacRae E, Maljkovic I, <strong>de</strong> M<strong>en</strong>doza C, Meyer L, Niels<strong>en</strong> C, Op <strong>de</strong> Coul EL, Ormaas<strong>en</strong> V, Paraskevis D, Perrin L, Puchhammer‐<br />
Stockl E, Ruiz L, Salmin<strong>en</strong> M, Schmit JC, Schnei<strong>de</strong>r F, Schuurman R, Soriano V, Stanczak G, Stanojevic M, Vandamme AM, Van<br />
Laethem K, Violin M,<br />
The calculated g<strong>en</strong>etic barrier for antiretroviral drug resistance substitutions is largely similar for differ<strong>en</strong>t HIV‐1 subtypes.<br />
JAIDS‐J ACQ IMM DEF 2006 Mar;41(3):352‐60<br />
3,946<br />
Weber J, Weberova J, Carob<strong>en</strong>e M, Mirza M, Martinez‐Picado J, Kazanjian P, Quinones‐Mateu ME.<br />
Use of a novel assay based on intact recombinant viruses expressing gre<strong>en</strong> (EGFP) or red (DsRed2) fluoresc<strong>en</strong>t proteins to<br />
examine the contribution of pol and <strong>en</strong>v g<strong>en</strong>es to overall HIV‐1 replicative fitness.<br />
J VIROL METHODS 136(1‐2):102‐117.<br />
2,097<br />
Weber R, Sabin CA, Friis‐Moller N, Reiss P, El‐Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G,<br />
Monforte A, Rick<strong>en</strong>bach M, Le<strong>de</strong>rgerber B, Phillips AN, Lundgr<strong>en</strong> JD.<br />
Liver‐related <strong>de</strong>aths in persons infected with the human immuno<strong>de</strong>fici<strong>en</strong>cy virus: the D:A:D study.<br />
ARCH INTERN MED 2006 Aug 14‐28;166(15):1632‐41.<br />
7,92<br />
Y<strong>en</strong>i P, Cooper DA, Aboulker JP, Babiker AG, Carey D, Darbyshire JH, Floridia M, Girard PM, Goodall RL, Hooker MH, Mijch A,<br />
Meiffredy V, Salzberger B. (INITIO Trial International Co‐ordinating Committee)<br />
Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regim<strong>en</strong>s containing non‐nucleosi<strong>de</strong><br />
reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: op<strong>en</strong>‐label randomised trial.<br />
LANCET 2006 Jul 22;368(9532):287‐98.<br />
25,8<br />
Pàgina 127/177
Change language